Maintenance Therapy Using Lenalidomide in Myeloma (IFM2005-02)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Intergroupe Francophone du Myelome
Celgene Corporation
Information provided by (Responsible Party):
University Hospital, Toulouse
ClinicalTrials.gov Identifier:
NCT00430365
First received: January 31, 2007
Last updated: November 8, 2013
Last verified: November 2013